Volume | 1 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Bio Rad Laboratories Inc | BIO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
274.06 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
1 | 1 | - | 261.59 - 473.50 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
03:59:14 | 1 | US$ 274.06 | USD |
Bio Rad Laboratories (BIO) Options Flow Summary
Bio Rad Laboratories Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.98B | 28.52M | - | 2.67B | -637.32M | -22.35 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Bio Rad Laboratories News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BIO Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 277.88 | 281.44 | 268.3325 | 273.82 | 238,633 | -3.82 | -1.37% |
1 Month | 330.50 | 339.90 | 268.3325 | 291.40 | 217,102 | -56.44 | -17.08% |
3 Months | 322.74 | 364.24 | 268.3325 | 320.51 | 214,053 | -48.68 | -15.08% |
6 Months | 281.29 | 364.24 | 268.3325 | 314.31 | 237,912 | -7.23 | -2.57% |
1 Year | 458.06 | 473.50 | 261.59 | 340.51 | 227,708 | -184.00 | -40.17% |
3 Years | 631.97 | 832.70 | 261.59 | 464.44 | 189,710 | -357.91 | -56.63% |
5 Years | 296.87 | 832.70 | 261.59 | 455.18 | 200,295 | -22.81 | -7.68% |
Bio Rad Laboratories Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier. |